+1 (888) 794-0077
« Return

You’ve Got Molecules, We’ve Got Solutions

We offer a true, single-platform, end-to-end solution that can be catered to your specific drug discovery and development needs – saving you money while providing industry-leading turnaround times.

With solutions for both small- and large-molecule development, our experts will collaborate with you every step of the way, providing high-quality data, insights, and helping you work through the unique challenges of drug discovery and development to efficiently advance your project to the next milestone.

To learn more, download our new small- and large-molecule brochures.


Small Molecule Brochure


Large Molecule Brochure

For more information, contact us today.

WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve the productivity of advancing healthcare products through cost-effective and efficient, socially responsible and sustainable solutions. With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec’s open-access platform is enabling more than 4,200 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that “every drug can be made and every disease can be treated.”

Related Articles

Preclinical Strategies for Safety Evaluation of Oligonucleotide Drugs

Preclinical Strategies for Safety Evaluation of Oligonucleotide Drugs

Oligonucleotide drugs (ONs) are synthetic molecules ranging from 12 to 30 nucleotides in length and typically made up of single or double strands of nucleotides. Through Watson-Crick base pairing, these drugs use target messenger RNA (mRNA), which results in the inhibition of gene expression and the prevention of erroneous protein production.

Ensuring drug product integrity: The crucial role of stability testing

Ensuring drug product integrity: The crucial role of stability testing

Ensuring the medications we rely on are safe and effective from the moment they leave the manufacturer to when they reach the patient involves rigorous stability testing, a critical process that safeguards drug product integrity under diverse environmental conditions. This testing is crucial in biopharmaceutical development to maintain the safety, efficacy, and quality of drug products (DP) and drug substances (DS). It accounts for potential degradation and the stability of different formulations and packaging configurations, providing data to inform labeling, storage, transport, and handling guidelines.